Colestasis intrahepática. A veces puede ser benigna y recurrente

García-Romero, Ruth; Morlan-Herrador, Laura; Ros-Arnal, Ignacio; Miramar, María Dolores; Molera-Busons, Cristina.
Gastroenterol. hepatol. (Ed. impr.) ; 44(10): 719-720, Dic. 2021.
Artículo en Español | IBECS (España) | ID: ibc-222073

Documentos relacionados

  1. Diagnostic considerations for cholestatic liver disease.
  2. [Current status of research on infantile cholestatic liver disease in China: a visualization analysis].
  3. Ursodeoxycholic acid in intrahepatic cholestasis of pregnancy: a secondary analysis of the PITCHES trial.
  4. Improvement of cholestatic episodes in patients with benign recurrent intrahepatic cholestasis (BRIC) treated with rifampicin. A long-term follow-up.
  5. Late-onset systemic lupus erythematosus-associated liver disease.
  6. Clinical and genetic characterization of pediatric patients with progressive familial intrahepatic cholestasis type 3 (PFIC3): identification of 14 novel ABCB4 variants and review of the literatures.
  7. Effect of ursodeoxycholic acid therapy due to pregnant intrahepatic cholestasis on chemerin and irisin levels.
  8. Serum Transaminase Monitoring and Successful Treatment of ADHD With Dextroamphetamine in a Patient With Progressive Familial Intrahepatic Cholestasis Type 3: A Case Report and Literature Review.
  9. The BACH project protocol: an international multicentre total Bile Acid Comparison and Harmonisation project and sub-study of the TURRIFIC randomised trial.
  10. Is ursodeoxycholic acid therapy due to pregnant intrahepatic cholestasis change the adiponectin and fibroblast growth factor-21 levels?-Pilot study.